Metamizole Sodium Salt

产品说明书

Print
Chemical Structure| 68-89-3 同义名 : 安乃近 ;Metamizole sodium; Dipyrone; Metamizole(sodium)
CAS号 : 68-89-3
货号 : A524152
分子式 : C13H16N3NaO4S
纯度 : 99+%
分子量 : 333.34
MDL号 : MFCD00020783
存储条件:

Pure form Inert atmosphere, room temperature

In solvent -20°C:3-6个月-80°C:12个月

溶解度 : -
动物实验配方:
生物活性
描述 Dipyrone (Metamizole) is a nonsteroidal compound with strong analgesic as well as antipyretic and spasmolytic properties[1]. Dipyrone has analgesic, spasmolytic, and antipyretic effects and is used to treat pain. The analgesic efficacy of intravenous dipyrone appears similar to that of intravenous paracetamol[2]. Dipyrone can be recommended for the treatment of cancer pain as an alternative to other non-opioids either alone or in combination with opioids[3]. Dipyrone can block both PG-dependent and PG-independent pathways of fever induced by LPS, which suggests that this drug has a profile of antipyretic action distinctly different from that of NSAIDs. The mechanism responsible for the spasmolytic effect of metamizole is associated with the inhibited release of intracellular Ca2+ as a result of the reduced synthesis of inositol phosphate[4].
临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT01850446 Influenza Phase 4 Recruiting December 2018 Russian Federation ... 展开 >> The Non-State Health Care Institution "Road Hospital of the Open Joint Stock Company" Russian Railways" Recruiting Chelyabinsk, Russian Federation, 454091 Contact: Yulia Shapovalova, MD PhD          Principal Investigator: Yulia Shapovalova, MD PhD          The State Budgetary Educational Institution of Higher Professional Education " Kazan State University of Medicine" Ministry of Health of the Russian Federation Recruiting Kazan, Russian Federation, 420012 Contact: Rustem Hamitov, MD, PhD, ScD, professor          Principal Investigator: Rustem Hamitov, MD, PhD, ScD, professor          Pirogov Russian National Research Medical University Not yet recruiting Moscow, Russian Federation, 117997 Contact: Boris Bart, MD, PhD, ScD, professor          Principal Investigator: Boris Bart, MD, PhD, ScD, professor          Pirogov Russian National Research Medical University Recruiting Moscow, Russian Federation, 117997 Contact: Marina Mikhaylusova, MD, PhD          Principal Investigator: Marina Mikhaylusova, MD, PhD          Limited Liability Company "Scientific Research Centre Eco-safety" Recruiting Saint Petersburg, Russian Federation, 196143 Contact: Rodion Oseshnyuk, MD, PhD          Principal Investigator: Rodion Oseshnyuk, MD, PhD          St. Petersburg State Budgetary Healthcare Institution "City polyclinic №106" Not yet recruiting Saint Petersburg, Russian Federation, 198328 Contact: Daniel Chizhov, MD          Principal Investigator: Daniel Chizhov, MD          Non-state health facility "Road Hospital Open Joint Stock Company" Russian Railways" Not yet recruiting Sankt Petersburg, Russian Federation, 195271 Contact: Konstantin Penkov, MD          Principal Investigator: Konstantin Penkov, MD          Regional State Budgetary Healthcare Institution "Clinical Hospital №1" Recruiting Smolensk, Russian Federation, 214006 Contact: Vladimir Rafalsky, PhD, professor          Principal Investigator: Vladimir Rafalsky, PhD, professor          State Federal-Funded Educational Institution of Higher Training Smolensk State Medical University of the Ministry of Health of the Russian Federation Not yet recruiting Smolensk, Russian Federation, 214019 Contact: Oleg Kozyrev, Prof          Principal Investigator: Oleg Kozyrev, Prof          St. Petersburg State Budgetary Health Care Institution " Nevsky Region Сity Polyclinic №25" Withdrawn St. Petersburg, Russian Federation, 193312 Federal State Budgetary Military Educational Institution of Higher Professional Education "Military-Medicine Academy named after S. M. Kirov" of Ministry of Defence of Russian Federation Recruiting St. Petersburg, Russian Federation, 194044 Contact: Konstantin Zhdanov, MD, PhD, ScD, Professor          Principal Investigator: Konstantin Zhdanov, MD, PhD, ScD, Professor          St. Petersburg State Budgetary Health Care Institution " City policlinic No. 117" Completed St. Petersburg, Russian Federation, 194358 收起 <<
NCT01389089 Edema Phase 4 Completed - Switzerland ... 展开 >> Luzerner Kantonsspital, Unfallchirurgie Luzern, Switzerland, 6000 16 收起 <<
NCT01847898 Vertebral Body Fractures Phase 4 Completed - Austria ... 展开 >> Universitätsklinik für Unfallchirurgie Graz, Austria AKH Wien, Austria Germany Universitätsklinikum Schleswig-Holstein Kiel, Germany Universitätsklinikum Münster, Germany Universitätsklinik und Poliklinik für Chirurgie Rostock, Germany 收起 <<
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

3.00mL

0.60mL

0.30mL

15.00mL

3.00mL

1.50mL

30.00mL

6.00mL

3.00mL

参考文献

[1]Lampl C, Likar R. Metamizol: Wirkmechanismen, Interaktionen und Agranulozytoserisiko [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis]. Schmerz. 2014 Dec;28(6):584-90. German

[2]de Leeuw TG, Dirckx M, Gonzalez Candel A, Scoones GP, Huygen FJPM, de Wildt SN. The use of dipyrone (metamizol) as an analgesic in children: What is the evidence? A review. Paediatr Anaesth. 2017 Dec;27(12):1193-1201

[3]Gaertner J, Stamer UM, Remi C, Voltz R, Bausewein C, Sabatowski R, Wirz S, Müller-Mundt G, Simon ST, Pralong A, Nauck F, Follmann M, Radbruch L, Meißner W. Metamizole/dipyrone for the relief of cancer pain: A systematic review and evidence-based recommendations for clinical practice. Palliat Med. 2017 Jan;31(1):26-34

[4]Jasiecka A, Maślanka T, Jaroszewski JJ. Pharmacological characteristics of metamizole. Pol J Vet Sci. 2014;17(1):207-14